Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Amortization of Goodwill (2023 - 2024)

Lexaria Bioscience's Amortization of Goodwill history spans 2 years, with the latest figure at $34329.0 for Q2 2024.

  • Quarterly results put Amortization of Goodwill at $34329.0 for Q2 2024, changed N/A from a year ago — trailing twelve months through Aug 2024 was $141090.0 (changed N/A YoY), and the annual figure for FY2024 was $57836.0, down 45.83%.
  • Amortization of Goodwill for Q2 2024 was $34329.0 at Lexaria Bioscience, down from $106761.0 in the prior quarter.
  • In the past five years, Amortization of Goodwill ranged from a high of $106761.0 in Q3 2023 to a low of $34329.0 in Q2 2024.